InsidersTradesSigma
Acutus Medical, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:acutus-medical-inc-330d36US·SEC (Form 4)Mcap 2M€Healthcare
Explore the full directors' dealings record of Acutus Medical, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Acutus Medical, Inc. has published 43 insider filings. Market capitalisation: €1.6m. The latest transaction was disclosed on 21 June 2022 (Attribution). Among the most active insiders: Hinrichs James F.. The full history is accessible without an account.
43
Insider Decl.
0
Thresholds
€43m
8 ops.
Buy Volume
€32,369
1 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
0.00 €
Income statement
Revenue20.2 M€
Gross profit1.0 M€5% margin
Net income−9.5 M€-47.4% margin
Balance sheet & cash
Market cap1.6 M€
Total debt35.8 M€
Free Cash Flow−31.8 M€
Last declaration on 21 June 2022
Declarations43 total
Executives◆Grant11SEC
08,400 shares0
Common Stock
SEC:0000950103-22-010954:0·
Executives◆Grant11SEC
08,400 shares0
Common Stock
SEC:0000950103-22-010953:0·
Executives◆Grant19SEC
08,400 shares0
Common Stock
SEC:0000950103-22-010955:0·
Executives◆Grant11SEC
08,400 shares0
Common Stock
SEC:0000950103-22-010950:0·
Executives▼Sale33SEC
€32,36960,000 shares@ €0.53951.97% mcap100.0% of flow
Common Stock
SEC:0000950103-22-010124:0·
Executives◆Grant19SEC
0100,000 shares0
Common Stock
SEC:0000950103-22-009981:0·
Executives●Retenue fiscale32SEC
€4,5743,896 shares@ €1.17410.28% mcap8.3% of flow
Common Stock
SEC:0000950103-22-006023:0·
Executives●Retenue fiscale17SEC
€861733 shares@ €1.17410.052% mcap9.7% of flow
Common Stock
SEC:0000950103-22-006021:0·
Executives●Retenue fiscale36SEC
€3,8133,248 shares@ €1.17410.23% mcap100.0% of flow
Common Stock
SEC:0000950103-22-006020:0·
Executives◆Grant19SEC
050,000 shares0
Common Stock
SEC:0000950103-22-002001:0·
Executives◆Grant11SEC
032,000 shares0
Common Stock
SEC:0000950103-22-002002:0·
Executives◆Grant9SEC
032,000 shares0
Common Stock
SEC:0000950103-22-002002·
Executives◆Grant13SEC
050,000 shares0
Common Stock
SEC:0000950103-22-002001·
Executives▲Purchase21SEC
€132,16640,000 shares@ €3.3042100.0% of flow
Common Stock
SEC:0000950103-21-017999·
Ideal exit: 12 Aug 2022 (T+270)
Executives▲Purchase36SEC
€132,16640,000 shares@ €3.30428.03% mcap50.0% of flow
Common Stock
SEC:0000950103-21-017999:0·
Ideal exit: 12 Aug 2022 (T+270)
Executives●Retenue fiscale17SEC
€3,999305 shares@ €13.1128100.0% of flow
Common Stock
SEC:0000950103-21-013064·
Executives●Retenue fiscale22SEC
€25,2031,922 shares@ €13.1128100.0% of flow
Common Stock
SEC:0000950103-21-013063·
Executives●Retenue fiscale40SEC
€25,2031,922 shares@ €13.11281.53% mcap45.8% of flow
Common Stock
SEC:0000950103-21-013063:0·
Executives●Retenue fiscale25SEC
€3,999305 shares@ €13.11280.24% mcap45.1% of flow
Common Stock
SEC:0000950103-21-013064:0·
25 of 43 declarations
About Acutus Medical, Inc.
Acutus Medical, Inc. is a company focused on developing technologies for the diagnosis and treatment of heart diseases. It is listed on NASDAQ under the ticker symbol ACUS.
